| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1826 | 2020 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 287 | 2021 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 169 | 2021 |
| The future of immune checkpoint cancer therapy after PD-1 and CTLA-4 AW Hahn, DM Gill, SK Pal, N Agarwal Immunotherapy 9 (8), 681-692, 2017 | 108 | 2017 |
| Incidence of immune-related adverse events with program death receptor-1-and program death receptor-1 ligand-directed therapies in genitourinary cancers BL Maughan, E Bailey, DM Gill, N Agarwal Frontiers in Oncology 7, 56, 2017 | 97 | 2017 |
| Telehealth in oncology: ASCO standards and practice recommendations RT Zon, EB Kennedy, K Adelson, S Blau, N Dickson, D Gill, N Laferriere, ... JCO Oncology Practice 17 (9), 546-564, 2021 | 92 | 2021 |
| PD-1 checkpoint inhibition: Toxicities and management AW Hahn, DM Gill, N Agarwal, BL Maughan Urologic Oncology: Seminars and Original Investigations 35 (12), 701-707, 2017 | 72 | 2017 |
| Meaningful activities in the nursing home JE Morley, CD Philpot, D Gill, M Berg-Weger Journal of the American Medical Directors Association 15 (2), 79-81, 2014 | 70 | 2014 |
| Systemic immunotherapy for urothelial cancer: current trends and future directions S Gupta, D Gill, A Poole, N Agarwal Cancers 9 (2), 15, 2017 | 67 | 2017 |
| Overview of current and future first-line systemic therapy for metastatic clear cell renal cell carcinoma DM Gill, AW Hahn, P Hale, BL Maughan Current treatment options in oncology 19, 1-12, 2018 | 60 | 2018 |
| Independent validation of effect of HSD3B1 genotype on response to androgen-deprivation therapy in prostate cancer N Agarwal, AW Hahn, DM Gill, JM Farnham, AI Poole, L Cannon-Albright JAMA oncology 3 (6), 856-857, 2017 | 60 | 2017 |
| Pharmacokinetics of a granisetron transdermal system for the treatment of chemotherapy-induced nausea and vomiting J Howell, J Smeets, HJ Drenth, D Gill Journal of Oncology Pharmacy Practice 15 (4), 223-231, 2009 | 58 | 2009 |
| Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC … AW Hahn, DM Gill, B Maughan, A Agarwal, L Arjyal, S Gupta, J Streeter, ... Oncotarget 8 (20), 33614, 2017 | 55 | 2017 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 46 | 2022 |
| Telehealth is a sustainable population health strategy to lower costs and increase quality of health care in rural Utah R Thota, DM Gill, JL Brant, TJ Yeatman, DS Haslem JCO Oncology Practice 16 (7), e557-e562, 2020 | 45 | 2020 |
| Baseball reminiscence league: A model for supporting persons with dementia C Wingbermuehle, D Bryer, M Berg-Weger, N Tumosa, J McGillick, ... Journal of the American Medical Directors Association 15 (2), 85-89, 2014 | 45 | 2014 |
| Association between androgen deprivation therapy and mortality among patients with prostate cancer and COVID-19 AL Schmidt, MD Tucker, Z Bakouny, C Labaki, CY Hsu, Y Shyr, ... JAMA network open 4 (11), e2134330-e2134330, 2021 | 38 | 2021 |
| Case report: pembrolizumab-induced Type 1 diabetes in a patient with metastatic cholangiocarcinoma MA Smith-Cohn, D Gill, BN Voorhies, N Agarwal, I Garrido-Laguna Immunotherapy 9 (10), 797-804, 2017 | 36 | 2017 |
| Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma JA Kuzman, DD Stenehjem, J Merriman, AM Agarwal, SB Patel, AW Hahn, ... BMC urology 17, 1-5, 2017 | 33 | 2017 |
| Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 Z Bakouny, C Labaki, P Grover, J Awosika, S Gulati, CY Hsu, ... JAMA oncology 9 (1), 128-134, 2023 | 29 | 2023 |
Roberto NussenzveigScientistVerified email at hci.utah.edu
